From: Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model
Direct costs of NSIs | Â |
---|---|
 | |
  NSI recipient – initial test | €38.76 |
  NSI recipient – follow-up test | €58.52 |
  Source patient (if known) | €43.91 |
€68.81 | |
 | |
  NSI from a known and infected source | €374.61 |
  NSI from an unknown source | €918.76 |
€2,377.44 | |
  Hepatitis B (year in which NSI occurred and per subsequent year for three years) |  |
  Hepatitis C (year in which NSI occurred only) | €16,127.76 |
  HIV (year in which NSI occurred and per subsequent year) | €16,999.83 |